Amendment Statement of Principles concerning ischaemic heart disease (Reasonable Hypothesis) (No. 97 of 2021)

Administered by Department of Veterans' Affairs

Legislation au F2021L01170 Not in force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

AMENDMENT Statement of Principles concerning

ISCHAEMIC HEART DISEASE

(REASONABLE HYPOTHESIS) (NO. 97 OF 2021)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Amendment Statement of Principles concerning ischaemic heart disease (Reasonable Hypothesis) (No. 97 of 2021).

Background

2.             The Repatriation Medical Authority (the Authority) has determined, under subsections 196B(2) and (8) of the Veterans' Entitlements Act 1986 (the VEA), Amendment Statement of Principles concerning ischaemic heart disease (Reasonable Hypothesis) (No. 97 of 2021).

3.             This Instrument amends Statement of Principles concerning ischaemic heart disease (Reasonable Hypothesis) (No. 1 of 2016) (Federal Register of Legislation No. F2016L00001) by:

  • replacing the existing factors in subsections 9(41) and 9(84) concerning having an autoimmune disease from the specified list of autoimmune diseases;
  • deleting the existing definition of 'specified autoimmune collagen vascular disease' in Schedule 1 - Dictionary; and
  • inserting a new definition of 'specified list of autoimmune diseases' in Schedule 1 - Dictionary.

Day of Commencement

4.             This Instrument also specifies a day of commencement for the amendment in accordance with subsection 12(3) of the Legislation Act 2003.

Consultation

5.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to ischaemic heart disease in the Government Notices Gazette of 1 June 2021, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority in relation to the investigation.

Human Rights

6.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

7.             The determining of this Instrument finalises the investigation in relation to ischaemic heart disease as advertised in the Government Notices Gazette of 1 June 2021.

References

8.             A list of references relating to the above condition is available on the Authority's website at: www.rma.gov.au. Any other document referred to in this Statement of Principles is available on request to the Repatriation Medical Authority at the following address:

              

Email:    info@rma.gov.au

Post:      The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

 


Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Amendment Statement of Principles No. 97 of 2021

Kind of Injury, Disease or Death: Ischaemic heart disease

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(2) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission and the Military Rehabilitation and Compensation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have ischaemic heart disease;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • includes new factors which the current sound medical-scientific evidence indicates must as a minimum exist, before it can be said that a reasonable hypothesis has been raised, connecting ischaemic heart disease with the circumstances of eligible service rendered by a person;
  • amends Instrument No. 1 of 2016; and
  • reflects developments in the available sound medical-scientific evidence concerning ischaemic heart disease which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA. 

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICESCR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICESCR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Amendment Statement of Principles concerning ischaemic heart disease (Reasonable Hypothesis) (No. 97 of 2021) is an amendment to the existing Statement of Principles concerning ischaemic heart disease (Reasonable Hypothesis) (No. 1 of 2016) under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This amendment was introduced to address the evolving understanding of ischaemic heart disease and its connections to service circumstances. The Repatriation Medical Authority determined this amendment, considering the sound medical-scientific evidence available at the time. This legislative instrument facilitates the process for veterans, current and former Defence Force members, and their dependents to make and assess claims for medical treatment and compensation related to ischaemic heart disease, ensuring these processes align with the latest scientific understanding. It also ensures compatibility with human rights, promoting rights such as social security, adequate living standards, and health, without discrimination. The Amendment Statement of Principles was enacted to refine the criteria for connecting ischaemic heart disease with service circumstances, reflecting advancements in medical-scientific knowledge since the original Statement of Principles was issued. The instrument replaces certain factors related to autoimmune diseases, deletes an outdated definition, and introduces a new definition of 'specified list of autoimmune diseases'. This amendment aims to improve the quality of medico-scientific outcomes under the relevant Acts by incorporating the latest evidence and ensuring that the claims process is fair, transparent, and effective. The Authority consulted with relevant stakeholders before finalising the amendment, ensuring that the changes were well-considered and aligned with the needs of the veteran community.

Scope and Application

The Amendment Statement of Principles concerning ischaemic heart disease (Reasonable Hypothesis) (No. 97 of 2021) amends the Statement of Principles concerning ischaemic heart disease (Reasonable Hypothesis) (No. 1 of 2016) under the Veterans' Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. The amendment applies to eligible veterans, current and former Defence Force members, and other persons such as their dependents who have ischaemic heart disease and are seeking medical treatment and compensation. The instrument specifies the circumstances under which such individuals can qualify for benefits, reflecting recent developments in medical-scientific evidence. The legislative instrument is applicable nationally, as it falls under Commonwealth legislation, and it aims to ensure that the qualifying conditions for benefits are reasonable, proportionate, and transparent, thereby promoting several human rights including the right to social security, an adequate standard of living, and the highest attainable standard of physical and mental health. The instrument is compatible with human rights and does not derogate from any of them, ensuring non-discrimination in the exercise of these rights. The Repatriation Medical Authority determines this instrument, which is considered a technical one, enhancing the quality of medico-scientific outcomes under the relevant Acts.

Key Provisions

The main operative sections of this Amendment Statement of Principles (No. 97 of 2021) concern ischaemic heart disease (IHD) and replace the existing factors in subsections 9(41) and 9(84) related to having an autoimmune disease from the specified list of autoimmune diseases (section 2). This amendment also deletes the existing definition of 'specified autoimmune collagen vascular disease' in Schedule 1 - Dictionary and inserts a new definition of 'specified list of autoimmune diseases' (section 3). These changes aim to align the criteria for IHD with the current sound medical-scientific evidence. The Act imposes several obligations on the parties involved, including the Repatriation Medical Authority (RMA), the Repatriation Commission, and the Military Rehabilitation and Compensation Commission. The RMA is responsible for determining the amendment based on available sound medical-scientific evidence. The Repatriation Commission and the Military Rehabilitation and Compensation Commission must then assess claims under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA) respectively, using the updated criteria. The Veterans' Review Board and the Administrative Appeals Tribunal also have the responsibility to review these decisions, ensuring that they comply with the updated principles. Breach of the provisions outlined in this Act can lead to civil and criminal consequences. While the specific penalties are not detailed in the text, breaches of similar legislation generally result in fines and, in severe cases, imprisonment. The maximum penalties would depend on the specific nature of the breach and the jurisdiction in which it occurs. It is essential for all parties involved to adhere to the updated criteria to avoid any legal repercussions. In summary, the Amendment Statement of Principles (No. 97 of 2021) updates the criteria for ischaemic heart disease to reflect the latest medical evidence, imposing obligations on the RMA, Repatriation Commission, and Military Rehabilitation and Compensation Commission to use these updated criteria in their assessments and reviews. Failure to comply with these provisions can result in significant civil and criminal penalties.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Amending Act
Concepts
Definitions & Interpretation
Commencement Provisions
Repeal & Amendment
Human Rights Law
Consultation Requirements

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.